These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Aspects of treatment of hypertrophic obstructive cardiomyopathy with emphasis on the role of percutaneous transluminal ablation of the myocardial septum]. Veselka J Vnitr Lek; 2001 Dec; 47(12):887-91. PubMed ID: 11826555 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy. Chen MS; McCarthy PM; Lever HM; Smedira NG; Lytle BL Am J Cardiol; 2004 Feb; 93(3):373-5. PubMed ID: 14759397 [TBL] [Abstract][Full Text] [Related]
10. Effects of percutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy on systolic and diastolic left ventricular function assessed by pressure-volume loops. Meliga E; Steendijk P; Valgimigli M; Ten Cate FJ; Serruys PW Am J Cardiol; 2008 Apr; 101(8):1179-84. PubMed ID: 18394455 [TBL] [Abstract][Full Text] [Related]
11. Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias. Manolis AG; Katsivas AG; Lazaris EE; Vassilopoulos CV; Louvros NE J Interv Card Electrophysiol; 1998 Mar; 2(1):71-6. PubMed ID: 9869999 [TBL] [Abstract][Full Text] [Related]
12. [Immediate and long-term results of conventionally performed radiofrequency catheter ablations of paroxysmal atrial fibrillation]. Lábrová R; Fiala M; Toman O; Spinar J Vnitr Lek; 2008 Oct; 54(10):953-60. PubMed ID: 19009761 [TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of radiofrequency catheter ablation versus medical treatment for paroxysmal supraventricular tachycardia in Japan. Ikeda T; Sugi K; Enjoji Y; Kasao M; Abe R; Ninomiya K; Yabuki S; Yamaguchi T J Cardiol; 1994; 24(6):461-8. PubMed ID: 7823285 [TBL] [Abstract][Full Text] [Related]
14. [Pre and Postoperative evaluation of the incidence of arrhythmia in patients undergoing corrective intervention for Ebstein anomaly]. Brancaccio G; Chauvaud S; Carpentier A Ital Heart J Suppl; 2000 Sep; 1(9):1173-9. PubMed ID: 11140286 [TBL] [Abstract][Full Text] [Related]
15. Arrhythmia and hypertrophic cardiomyopathy. Shakespeare CF; Keeling PJ; Slade AK; McKenna WJ Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():31-6. PubMed ID: 1307192 [TBL] [Abstract][Full Text] [Related]
16. [The influence of radiofrequency (RF) ablation of the atrioventricular junction in atrial fibrillation on left ventricular systolic function, exercise tolerance and quality of life]. Lelakowski J; Majewski J; Bigaj J; Szczepkowski J; Dreher A; Bednarek J Przegl Lek; 2009; 66(5):222-7. PubMed ID: 19739578 [TBL] [Abstract][Full Text] [Related]
18. Management of atrial fibrillation in the elderly. Aronow WS Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738 [TBL] [Abstract][Full Text] [Related]
19. [Successful weaning from cardiopulmonary bypass with administration of landiolol hydrochloride in a patient with hypertrophic obstructive cardiomyopathy]. Shinzawa M; Nohmi T; Tsuzuki M; Ohnishi Y; Kuro M Masui; 2005 Jul; 54(7):785-7. PubMed ID: 16026062 [TBL] [Abstract][Full Text] [Related]
20. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Guo H; Wang P; Xing Y; Peng F; Jiang J; Yang B; You B; Qiu Y; Lee JD J Electrocardiol; 2007 Oct; 40(4):356.e1-6. PubMed ID: 17316677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]